Skip to main content

Published locations for EMA panel backs baricitinib for moderate to severe atopic dermatitis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. EMA panel backs baricitinib for moderate to severe atopic dermatitis

User login

  • Reset your password
  • /content/ema-panel-backs-baricitinib-moderate-severe-atopic-dermatitis
  • /edermatologynews/article/228977/atopic-dermatitis/ema-panel-backs-baricitinib-moderate-severe-atopic
  • /familypracticenews/article/228977/atopic-dermatitis/ema-panel-backs-baricitinib-moderate-severe
  • /internalmedicinenews/article/228977/atopic-dermatitis/ema-panel-backs-baricitinib-moderate-severe
  • /rheumatologynews/article/228977/atopic-dermatitis/ema-panel-backs-baricitinib-moderate-severe-atopic
  • /rheumatology/article/228977/atopic-dermatitis/ema-panel-backs-baricitinib-moderate-severe-atopic
  • /internalmedicine/article/228977/atopic-dermatitis/ema-panel-backs-baricitinib-moderate-severe-atopic
  • /dermatology/article/228977/atopic-dermatitis/ema-panel-backs-baricitinib-moderate-severe-atopic
  • /familymedicine/article/228977/atopic-dermatitis/ema-panel-backs-baricitinib-moderate-severe-atopic